Cargando…

Clinical Outcomes of Patients with Chronic Neuropathic Form of Gaucher Disease in the Spanish Real-World Setting: A Retrospective Study

This was a retrospective, multicenter study that aimed to report the characteristics of type 3 Gaucher disease (GD3) patients in Spain, including the genotype, phenotype, therapeutic options, and treatment responses. A total of 19 patients with GD3 from 10 Spanish hospitals were enrolled in the stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanescu, Sinziana, Correcher Medina, Patricia, del Castillo, Francisco J., Alonso Luengo, Olga, Arto Millan, Luis Maria, Belanger Quintana, Amaya, Camprodon Gomez, Maria, Diez Langhetée, Lydia, Garcia Campos, Oscar, Matas Garcia, Ana, Perez-Moreno, Jimena, Rubio Gribble, Barbara, Visa-Reñé, Nuria, Giraldo-Castellano, Pilar, O’Callaghan Gordo, Mar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603893/ https://www.ncbi.nlm.nih.gov/pubmed/37893235 http://dx.doi.org/10.3390/biomedicines11102861

Ejemplares similares

Síndrome de deficiencia de GLUT1 y COVID-19
por: Arrieta Blanco, Francisco, et al.
Publicado: (2021)

Chronic pain in Gaucher disease: skeletal or neuropathic origin?
por: Devigili, Grazia, et al.
Publicado: (2017)

Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease
por: Wei, Jianshe, et al.
Publicado: (2021)

Interorgan amino acid interchange in propionic acidemia: the missing key to understanding its physiopathology
por: Stanescu, Sinziana, et al.
Publicado: (2022)

Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
por: Liu, Ganqiang, et al.
Publicado: (2016)

Severe anemia in patients with Propionic acidemia is associated with branched-chain amino acid imbalance
por: Stanescu, Sinziana, et al.
Publicado: (2021)

Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease
por: Andrade-Campos, Marcio, et al.
Publicado: (2017)

Plasma CoQ10 Status in Patients with Propionic Acidaemia and Possible Benefit of Treatment with Ubiquinol
por: Stanescu, Sinziana, et al.
Publicado: (2022)

New challenges in management of phenylketonuria in pregnancy: a case report
por: Ugalde-Abiega, Beatriz, et al.
Publicado: (2023)

Long‐term follow‐up with filter paper samples in patients with propionic acidemia
por: Stanescu, Sinziana, et al.
Publicado: (2020)

Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease
por: Ivanova, Margarita M., et al.
Publicado: (2021)

Gaucher Disease and Gaucher Cells
por: Gözdaşoğlu, Sevgi
Publicado: (2015)

Novel Management and Screening Approaches for Haematological Complications of Gaucher’s Disease
por: Giraldo, Pilar, et al.
Publicado: (2021)

COVID-19: The disease of the anthropocene
por: O'Callaghan-Gordo, Cristina, et al.
Publicado: (2020)

Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry
por: Rosenbloom, Barry E., et al.
Publicado: (2022)

Mitochondrial bioenergetic is impaired in Monocarboxylate transporter 1 deficiency: a new clinical case and review of the literature
por: Stanescu, Sinziana, et al.
Publicado: (2022)

Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)
por: Zimran, Ari, et al.
Publicado: (2017)

Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish
por: Artola, Marta, et al.
Publicado: (2019)

Beneficial Effect of N-Carbamylglutamate in a Neonatal Form of Multiple Acyl-CoA Dehydrogenase Deficiency
por: Stanescu, Sinziana, et al.
Publicado: (2020)

P1541: PRELIMINARY RESULTS OF TWO YEARS FOLLOW-UP OF TYPE 1 GAUCHER DISEASE PATIENTS TREATED WITH ELIGLUSTAT IN TRAZELGA PROJECT.
por: Serrano-Gonzalo, I., et al.
Publicado: (2022)

Gaucher Cells or Pseudo-Gaucher Cells: That’s the Question
por: Gören Şahin, Deniz, et al.
Publicado: (2014)

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism
por: Furderer, Makaila L., et al.
Publicado: (2022)

Identification of risk features for complication in Gaucher’s disease patients: a machine learning analysis of the Spanish registry of Gaucher disease
por: Andrade-Campos, Marcio M., et al.
Publicado: (2020)

Health effects of non-occupational exposure to oil extraction
por: O’Callaghan-Gordo, Cristina, et al.
Publicado: (2016)

Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher’s disease
por: Roca-Espiau, Mercedes, et al.
Publicado: (2019)

Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)
por: Hughes, Derralynn A., et al.
Publicado: (2022)

Gaucher's disease
por: Bohra, Vijay, et al.
Publicado: (2011)

Gaucher’s Disease
Publicado: (1916)

Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula
por: Giraldo, Pilar, et al.
Publicado: (2012)

Promising Effect of High Dose Ambroxol Treatment on Neurocognition and Motor Development in a Patient With Neuropathic Gaucher Disease 2
por: Aries, Charlotte, et al.
Publicado: (2022)

Serum Phospholipid Profile Changes in Gaucher Disease and Parkinson’s Disease
por: López de Frutos, Laura, et al.
Publicado: (2022)

Advantages of digital technology in the assessment of bone marrow involvement in Gaucher's disease
por: Valero-Tena, Esther, et al.
Publicado: (2023)

The cognitive profile of type 1 Gaucher disease patients
por: Biegstraaten, Marieke, et al.
Publicado: (2012)

Recommendations on the follow‐up of patients with Gaucher disease in Spain: Results from a Delphi survey
por: Giraldo, Pilar, et al.
Publicado: (2022)

Gastrointestinal Involvement in Dermatomyositis
por: Matas-Garcia, Ana, et al.
Publicado: (2022)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

Gaucher-Associated Parkinsonism
por: Li, Yaqiong, et al.
Publicado: (2015)

Gaucher disease: an update
por: Dumitrascu, Dan L.
Publicado: (2021)

Gaucher Disease for Hematologists
por: Özdemir, Gül Nihal, et al.
Publicado: (2022)

PB2551: GAUCHER DISEASE CURRICULUM: INCORPORATING GAUCHER DISEASE IN THE FIELD OF HEMATOLOGY
por: Symeonidis, Argiris, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qfucba28ag1msp4lea0in1v0lp